Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Low Back Pain; Pain; Spasm
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy; Immune System Diseases; Myelodysplastic Syndromes; Chemical and Drug Induced Liver Injury; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Mast-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Pneumonia, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Deafness; Encephalitis, Japanese; Glomerulonephritis; Glomerulonephritis, IGA; Graft vs Host Disease; Leukemia, Myeloid, Acute; Multiple Sclerosis, Chronic Progressive; Pain; Pneumonia; Severe Acute Respiratory Syndrome; Vestibular Neuronitis; Acne Vulgaris; Anemia; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Dermatitis; Endocrine System Diseases; Inflammation; Leukemia; Lymphoma; Multiple Sclerosis; Osteoarthritis; Serum Sickness; Uveitis, Posterior
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine transporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Obesity
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Opioid receptors; mu/kappa/delta agonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL; RECTAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Chronic Pain; Acute Pain; Pain; Pain, Postoperative
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Glaucoma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thiazide-sensitive sodium-chloride cotransporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Cardiovascular Diseases; Hypertension
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety; Neurotic Disorders; Pruritus; Skin Diseases; Urticaria
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Progesterone receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL; SUBCUTANEOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Pregnancy; Alzheimer Disease; Endometrial Hyperplasia; HIV Infections; Myelodysplastic Syndromes; Pain; Primary Ovarian Insufficiency; Sleep Apnea Syndromes; Coronary Disease; Diabetes Mellitus; Endometrial Neoplasms; Heart Diseases; Hot Flashes; Hypercholesterolemia; Hypertension; Infertility; Kidney Neoplasms; Lupus Erythematosus, Systemic; Menopause; Menorrhagia; Myocardial Ischemia; Osteoporosis; Prostatic Neoplasms; Thrombosis; Turner Syndrome; Carcinoma, Renal Cell; Endometriosis; Hyperplasia; Neoplasms; Uterine Hemorrhage
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Acetylcholinesterase inhibitor
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Monoamine oxidase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY
THERAPEUTIC INDICATION: Depression; Depressive Disorder; Depressive Disorder, Major
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thiazide-sensitive sodium-chloride cotransporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Diabetes Mellitus, Type 1; Atherosclerosis; Cerebrovascular Disorders; Coronary Disease; Death, Sudden, Cardiac; Diabetes Mellitus; Diabetes Mellitus, Type 2; Essential Hypertension; Heart Diseases; Hypercholesterolemia; Myocardial Infarction; Myocardial Ischemia; Angina Pectoris; Cardiovascular Diseases; Glomerulonephritis; Heart Failure; Hypertension; Kidney Failure, Chronic; Nephrotic Syndrome; Toxemia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thiazide-sensitive sodium-chloride cotransporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated T-type calcium channel blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Migraine Disorders; Complex Regional Pain Syndromes; Neuralgia; Epilepsy, Absence; Irritable Bowel Syndrome; Seizures; Epilepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine transporter releasing agent
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Cocaine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Narcolepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel alpha subunit blocker
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mu opioid receptor agonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Compartment Syndromes; Osteoarthritis, Hip; Pain
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thiazide-sensitive sodium-chloride cotransporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adrenergic receptor alpha-2 agonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscarinic acetylcholine receptor M1 antagonist
ROUTE OF ADMINISTRATION: INTRAMUSCULAR
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Hypotension, Orthostatic; Orthostatic Intolerance; Prediabetic State; Amyotrophic Lateral Sclerosis; Blood Coagulation Disorders; Bradycardia; Breast Neoplasms; Heart Arrest; Hemorrhage; Hypospadias; Pneumonia, Ventilator-Associated; Rhinitis, Allergic, Seasonal; Amblyopia; Anisometropia; Dwarfism, Pituitary; Headache; Myopia; Pain; Strabismus; Digestive System Diseases; Mydriasis; Poisoning
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: DENTAL; INHALATION; INJECTION; INTRA-ARTICULAR; INTRAMUSCULAR; INTRAVITREAL; NASAL; SUSPENSION; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER; PEDIATRICS; RESPIRATORY
THERAPEUTIC INDICATION: Fibroma; Hearing Loss; Mucositis; Neurilemmoma; Rotator Cuff Injuries; Alopecia Areata; Breast Neoplasms; Cataract; Dermatitis, Atopic; Diabetic Retinopathy; Glaucoma; Hand Dermatoses; Humeral Fractures; Keloid; Lichen Planus; Pemphigoid, Benign Mucous Membrane; Psoriasis; Shoulder Pain; Uveomeningoencephalitic Syndrome; Vitiligo; Chalazion; Cough; Cystitis, Interstitial; Dupuytren Contracture; Eye Injuries; Lichen Planus, Oral; Macular Degeneration; Macular Edema; Optic Neuropathy, Ischemic; Osteoarthritis, Hip; Osteoarthritis, Knee; Otitis Media with Effusion; Pemphigus; Radiculopathy; Retinal Vein Occlusion; Rhinitis; Tendinopathy; Uveitis; Vitreoretinopathy, Proliferative; Wet Macular Degeneration; Anemia; Arthritis, Gouty; Arthritis, Rheumatoid; Asthma; Bursitis; Dermatitis; Multiple Sclerosis; Mycoses; Nasal Obstruction; Osteoarthritis; Pain; Rhinitis, Allergic, Seasonal; Serum Sickness; Skin Diseases; Tennis Elbow; Tenosynovitis; Tuberculosis, Pulmonary; Wounds and Injuries
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscarinic acetylcholine receptor M3 antagonist
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Parkinson Disease; Presbyopia; Sialorrhea; Eye Diseases; Mydriasis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thiazide-sensitive sodium-chloride cotransporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown